Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available.
Foltz L, Pica GM, Zerazhi H, Van Droogenbroeck J, Visanica S, Báez de la Fuente E, Leber B, de Almeida AM, Ranta D, Kiladjian JJ, Chrit L, Kandra A, Morando J, Devos T. Foltz L, et al. Among authors: kandra a. Leuk Lymphoma. 2019 Dec;60(14):3493-3502. doi: 10.1080/10428194.2019.1636985. Epub 2019 Jul 30. Leuk Lymphoma. 2019. PMID: 31359808 Clinical Trial.
Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C. Lesogor A, et al. Among authors: kandra a. Eur J Heart Fail. 2013 Nov;15(11):1236-44. doi: 10.1093/eurjhf/hft089. Epub 2013 Jun 19. Eur J Heart Fail. 2013. PMID: 23787721 Free article. Clinical Trial.
Risk factors and management of pasireotide-associated hyperglycemia in acromegaly.
Gadelha MR, Gu F, Bronstein MD, Brue TC, Fleseriu M, Shimon I, van der Lely AJ, Ravichandran S, Kandra A, Pedroncelli AM, Colao AAL. Gadelha MR, et al. Among authors: kandra a. Endocr Connect. 2020 Dec;9(12):1178-1190. doi: 10.1530/EC-20-0361. Endocr Connect. 2020. PMID: 33434154 Free PMC article.
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J; ATMOSPHERE Investigators. Krum H, et al. Among authors: kandra a. Eur J Heart Fail. 2011 Jan;13(1):107-14. doi: 10.1093/eurjhf/hfq212. Eur J Heart Fail. 2011. PMID: 21169387 Free article.
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
Greene SJ, Maggioni AP, Fonarow GC, Solomon SD, Böhm M, Kandra A, Prescott MF, Reimund B, Hua TA, Lesogor A, Zannad F, Gheorghiade M; ASTRONAUT Investigators and Coordinators. Greene SJ, et al. Among authors: kandra a. Eur J Heart Fail. 2015 Jan;17(1):98-108. doi: 10.1002/ejhf.201. Eur J Heart Fail. 2015. PMID: 25597870 Free article.
25 results